Rational Use of Personal Protective Equipment During COVID-19 Pandemic

NCT ID: NCT04712045

Last Updated: 2021-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

67 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-08-01

Study Completion Date

2020-12-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to improve the personal protective equipment (PPE) used while treating patients with COVID-19, to protect staff and avoid cross-infection of patients. Protecting staff from infection during the Covid pandemic is critical to maintaining health services. Mistakes in using protective equipment (PPE) are the commonest avoidable factor in staff becoming infected at work. Recently, intensive care doctors have also reported an increase in the spread of dangerous multi-resistant bacteria between patients, which appears likely to be transmitted between patients by Level 2 PPE worn by staff (specifically gown sleeves). This study therefore seeks to develop and test a new protocol to decrease cross-infection risks whilst using Level 2 PPE.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19 Personal Protective Equipment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

New PPE

Use of Short sleeve gown and single pair of gloves

Group Type EXPERIMENTAL

New PPE

Intervention Type OTHER

The use of a new protocol of level 2 PPE which involves wearing a short-sleeve gown and a single pair of gloves

Old PPE

Use of Long sleeve gown and double pairs of gloves

Group Type ACTIVE_COMPARATOR

Old PPE

Intervention Type OTHER

The use of a standard protocol of level 2 PPE which involves wearing a long-sleeve gown and double pairs of gloves

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

New PPE

The use of a new protocol of level 2 PPE which involves wearing a short-sleeve gown and a single pair of gloves

Intervention Type OTHER

Old PPE

The use of a standard protocol of level 2 PPE which involves wearing a long-sleeve gown and double pairs of gloves

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. NHS staff and works in the Adult Intensive Care Unit, Neuro Intensive Care Unit or Cardio-thoracic Intensive Care Unit
2. Trained in the correct use of Level 2 PPE according to current guidance
3. Trained in ICU COVID19 Intubation and Proning protocols
4. Willing and able to give informed consent for participation in the study.

Exclusion Criteria

1\. taking any medication which can cause photosensitivity reactions in the preceding 3 months
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oxford

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ProfessorPeterMcculloch

Professor of Surgical Science and Practice

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter McCulloch

Role: PRINCIPAL_INVESTIGATOR

University of Oxford

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Professor Peter McCulloch

Oxford, Oxfordshire, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRAS287865

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

UVA Light Device to Treat COVID-19
NCT04572399 COMPLETED NA